This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jul 21;375(3):278-9.

doi: 10.1056/NEJMe1606919.

Hormone-Replacement Therapy for Melanocyte-Stimulating Hormone Deficiency

Marc L Reitman¹

Affiliations

Affiliation

¹ From the Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

PMID: 27468065
DOI: 10.1056/NEJMe1606919

Editorial

Hormone-Replacement Therapy for Melanocyte-Stimulating Hormone Deficiency

Marc L Reitman. N Engl J Med. 2016.

. 2016 Jul 21;375(3):278-9.

doi: 10.1056/NEJMe1606919.

Author

Marc L Reitman¹

Affiliation

¹ From the Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

PMID: 27468065
DOI: 10.1056/NEJMe1606919

No abstract available

PubMed Disclaimer

Comment on

Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist.
Kühnen P, Clément K, Wiegand S, Blankenstein O, Gottesdiener K, Martini LL, Mai K, Blume-Peytavi U, Grüters A, Krude H. Kühnen P, et al. N Engl J Med. 2016 Jul 21;375(3):240-6. doi: 10.1056/NEJMoa1512693. N Engl J Med. 2016. PMID: 27468060 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information